Skip Header

 
Contribute Send feedback
Read comments (1) or add your own

Reviewed, UniProtKB/Swiss-Prot P35658 (NU214_HUMAN)

Last modified June 16, 2009. Version 93. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Nuclear pore complex protein Nup214
Alternative name(s):
    Nucleoporin Nup214
    214 kDa nucleoporin
    Protein CAN
Gene names
Name: NUP214
Synonyms: CAIN, CAN, KIAA0023
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length2090 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

May serve as a docking site in the receptor-mediated import of substrates across the nuclear pore complex.

Subunit structure

Homodimer. Interacts with DDX19, NUP88, XPO1 and XPO5. Ref.7 Ref.8

Subcellular location

Nucleusnuclear pore complex. Note: Cytoplasmic filaments.

Tissue specificity

Expressed in thymus, spleen, bone marrow, kidney, brain and testis, but hardly in all other tissues or in whole embryos during development.

Domain

Contains FG repeats.

Post-translational modification

Probably glycosylated as it reacts with wheat germ agglutinin (WGA).

Involvement in disease

A chromosomal aberration involving NUP214 is found in a subset of acute myeloid leukemia (AML); also known as acute non-lymphocytic leukemia. Translocation t(6;9)(p23;q34) with DEK. It results in the formation of a DEK-CAN fusion gene.

A chromosomal aberration involving NUP214 is found in some cases of acute undifferentiated leukemia (AUL). Translocation t(6;9)(q21;q34.1) with SET.

Defects in NUP214 may be a cause of breast cancer.

Alternative products

This entry describes 5 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: P35658-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: P35658-2)

The sequence of this isoform differs from the canonical sequence as follows:
     590-601: KFTAAATSTPVS → N
Note: No experimental confirmation available.
Isoform 3 (identifier: P35658-3)

The sequence of this isoform differs from the canonical sequence as follows:
     648-648: S → SA
Note: No experimental confirmation available.
Isoform 4 (identifier: P35658-4)

The sequence of this isoform differs from the canonical sequence as follows:
     590-601: KFTAAATSTPVS → N
     648-648: S → SA
Isoform 5 (identifier: P35658-5)

The sequence of this isoform differs from the canonical sequence as follows:
     590-601: KFTAAATSTPVS → N
     1139-1148: Missing.
     2026-2090: FGSSSNTTSF...SVQGFGGWRS → SLAMSLSPTL...PTDFWFWDPE

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 20902090Nuclear pore complex protein Nup214
PRO_0000204861

Regions

Domain740 – 76829Leucine-zipper 1
Domain861 – 88222Leucine-zipper 2
Region481 – 2076159611 X 5 AA approximate repeats
Region1409 – 208467618 X 4 AA approximate repeats
Region1427 – 208565911 X 3 AA approximate repeats
Compositional bias1213 – 2090878Pro/Ser/Thr-rich

Sites

Site812 – 8132Breakpoint

Amino acid modifications

Modified residue401Phosphoserine Ref.12
Modified residue4161Phosphothreonine Ref.14
Modified residue4301Phosphoserine Ref.9 Ref.15
Modified residue4331Phosphoserine Ref.15
Modified residue4341Phosphothreonine Ref.15
Modified residue4371Phosphothreonine Ref.9 Ref.15
Modified residue4391Phosphothreonine Ref.15
Modified residue6461Phosphoserine Ref.14
Modified residue6511Phosphoserine Ref.14
Modified residue6571Phosphoserine Ref.14
Modified residue6661Phosphoserine Ref.14 Ref.15 Ref.13
Modified residue6701Phosphothreonine Ref.14 Ref.15
Modified residue6781Phosphoserine Ref.14 Ref.15
Modified residue9401Phosphoserine Ref.14 Ref.15 Ref.10
Modified residue9701Phosphoserine Ref.14 Ref.15
Modified residue9741Phosphoserine Ref.15
Modified residue9851Phosphoserine Ref.15
Modified residue9871Phosphothreonine Ref.15
Modified residue9891Phosphoserine Ref.15
Modified residue10811Phosphoserine Ref.14 Ref.10 Ref.11
Modified residue11561Phosphothreonine Ref.14
Modified residue11811Phosphoserine Ref.14
Modified residue12031Phosphothreonine Ref.14
Modified residue13121Phosphothreonine Ref.14
Modified residue13331Phosphoserine Ref.14
Modified residue13561Phosphoserine Ref.14
Modified residue19631Phosphoserine Ref.15

Natural variations

Alternative sequence590 – 60112KFTAA…STPVS → N in isoform 2, isoform 4 and isoform 5.
VSP_034896
Alternative sequence6481S → SA in isoform 3 and isoform 4.
VSP_034897
Alternative sequence1139 – 114810Missing in isoform 5.
VSP_034898
Alternative sequence2026 – 209065FGSSS…GGWRS → SLAMSLSPTLKGRLLLMRPK AGGGREQAAPGRKSNESRSL GHLCMERALTSPLKVWEQQQ HHILRHARESECPHFRITVP TDFWFWDPE in isoform 5.
VSP_034899
Natural variant4241G → A in a breast cancer sample; somatic mutation. Ref.17
VAR_035856
Natural variant5741P → S: dbSNP rs103612. Ref.1 Ref.5
VAR_045691
Natural variant13781P → L in a breast cancer sample; somatic mutation. Ref.17
VAR_035857
Natural variant13921A → V in a breast cancer sample; somatic mutation. Ref.17
VAR_035858

Experimental info

Sequence conflict1491G → A in CAA45535. Ref.1
Sequence conflict1751A → D in CAA45535. Ref.1
Sequence conflict1091 – 10922AA → QL in CAA45535. Ref.1
Sequence conflict18721S → N in AAH45620. Ref.5

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 [UniParc].

Last modified July 22, 2008. Version 2.
Checksum: EE6F0F3DE3D522C6

FASTA2,090213,620
        10         20         30         40         50         60 
MGDEMDAMIP EREMKDFQFR ALKKVRIFDS PEELPKERSS LLAVSNKYGL VFAGGASGLQ 

        70         80         90        100        110        120 
IFPTKNLLIQ NKPGDDPNKI VDKVQGLLVP MKFPIHHLAL SCDNLTLSAC MMSSEYGSII 

       130        140        150        160        170        180 
AFFDVRTFSN EAKQQKRPFA YHKLLKDAGG MVIDMKWNPT VPSMVAVCLA DGSIAVLQVT 

       190        200        210        220        230        240 
ETVKVCATLP STVAVTSVCW SPKGKQLAVG KQNGTVVQYL PTLQEKKVIP CPPFYESDHP 

       250        260        270        280        290        300 
VRVLDVLWIG TYVFAIVYAA ADGTLETSPD VVMALLPKKE EKHPEIFVNF MEPCYGSCTE 

       310        320        330        340        350        360 
RQHHYYLSYI EEWDLVLAAS AASTEVSILA RQSDQINWES WLLEDSSRAE LPVTDKSDDS 

       370        380        390        400        410        420 
LPMGVVVDYT NQVEITISDE KTLPPAPVLM LLSTDGVLCP FYMINQNPGV KSLIKTPERL 

       430        440        450        460        470        480 
SLEGERQPKS PGSTPTTPTS SQAPQKLDAS AAAAPASLPP SSPAAPIATF SLLPAGGAPT 

       490        500        510        520        530        540 
VFSFGSSSLK SSATVTGEPP SYSSGSDSSK AAPGPGPSTF SFVPPSKASL APTPAASPVA 

       550        560        570        580        590        600 
PSAASFSFGS SGFKPTLEST PVPSVSAPNI AMKPSFPPST SAVKVNLSEK FTAAATSTPV 

       610        620        630        640        650        660 
SSSQSAPPMS PFSSASKPAA SGPLSHPTPL SAPPSSVPLK SSVLPSPSGR SAQGSSSPVP 

       670        680        690        700        710        720 
SMVQKSPRIT PPAAKPGSPQ AKSLQPAVAE KQGHQWKDSD PVMAGIGEEI AHFQKELEEL 

       730        740        750        760        770        780 
KARTSKACFQ VGTSEEMKML RTESDDLHTF LLEIKETTES LHGDISSLKT TLLEGFAGVE 

       790        800        810        820        830        840 
EAREQNERNR DSGYLHLLYK RPLDPKSEAQ LQEIRRLHQY VKFAVQDVND VLDLEWDQHL 

       850        860        870        880        890        900 
EQKKKQRHLL VPERETLFNT LANNREIINQ QRKRLNHLVD SLQQLRLYKQ TSLWSLSSAV 

       910        920        930        940        950        960 
PSQSSIHSFD SDLESLCNAL LKTTIESHTK SLPKVPAKLS PMKQAQLRNF LAKRKTPPVR 

       970        980        990       1000       1010       1020 
STAPASLSRS AFLSQRYYED LDEVSSTSSV SQSLESEDAR TSCKDDEAVV QAPRHAPVVR 

      1030       1040       1050       1060       1070       1080 
TPSIQPSLLP HAAPFAKSHL VHGSSPGVMG TSVATSASKI IPQGADSTML ATKTVKHGAP 

      1090       1100       1110       1120       1130       1140 
SPSHPISAPQ AAAAAALRRQ MASQAPAVNT LTESTLKNVP QVVNVQELKN NPATPSTAMG 

      1150       1160       1170       1180       1190       1200 
SSVPYSTAKT PHPVLTPVAA NQAKQGSLIN SLKPSGPTPA SGQLSSGDKA SGTAKIETAV 

      1210       1220       1230       1240       1250       1260 
TSTPSASGQF SKPFSFSPSG TGFNFGIITP TPSSNFTAAQ GATPSTKESS QPDAFSSGGG 

      1270       1280       1290       1300       1310       1320 
SKPSYEAIPE SSPPSGITSA SNTTPGEPAA SSSRPVAPSG TALSTTSSKL ETPPSKLGEL 

      1330       1340       1350       1360       1370       1380 
LFPSSLAGET LGSFSGLRVG QADDSTKPTN KASSTSLTST QPTKTSGVPS GFNFTAPPVL 

      1390       1400       1410       1420       1430       1440 
GKHTEPPVTS SATTTSVAPP AATSTSSTAV FGSLPVTSAG SSGVISFGGT SLSAGKTSFS 

      1450       1460       1470       1480       1490       1500 
FGSQQTNSTV PPSAPPPTTA ATPLPTSFPT LSFGSLLSSA TTPSLPMSAG RSTEEATSSA 

      1510       1520       1530       1540       1550       1560 
LPEKPGDSEV SASAASLLEE QQSAQLPQAP PQTSDSVKKE PVLAQPAVSN SGTAASSTSL 

      1570       1580       1590       1600       1610       1620 
VALSAEATPA TTGVPDARTE AVPPASSFSV PGQTAVTAAA ISSAGPVAVE TSSTPIASST 

      1630       1640       1650       1660       1670       1680 
TSIVAPGPSA EAAAFGTVTS GSSVFAQPPA ASSSSAFNQL TNNTATAPSA TPVFGQVAAS 

      1690       1700       1710       1720       1730       1740 
TAPSLFGQQT GSTASTAAAT PQVSSSGFSS PAFGTTAPGV FGQTTFGQAS VFGQSASSAA 

      1750       1760       1770       1780       1790       1800 
SVFSFSQPGF SSVPAFGQPA SSTPTSTSGS VFGAASSTSS SSSFSFGQSS PNTGGGLFGQ 

      1810       1820       1830       1840       1850       1860 
SNAPAFGQSP GFGQGGSVFG GTSAATTTAA TSGFSFCQAS GFGSSNTGSV FGQAASTGGI 

      1870       1880       1890       1900       1910       1920 
VFGQQSSSSS GSVFGSGNTG RGGGFFSGLG GKPSQDAANK NPFSSASGGF GSTATSNTSN 

      1930       1940       1950       1960       1970       1980 
LFGNSGAKTF GGFASSSFGE QKPTGTFSSG GGSVASQGFG FSSPNKTGGF GAAPVFGSPP 

      1990       2000       2010       2020       2030       2040 
TFGGSPGFGG VPAFGSAPAF TSPLGSTGGK VFGEGTAAAS AGGFGFGSSS NTTSFGTLAS 

      2050       2060       2070       2080       2090 
QNAPTFGSLS QQTSGFGTQS SGFSGFGSGT GGFSFGSNNS SVQGFGGWRS 

« Hide

Isoform 2.

Checksum: 159D32101C9DF54A
Show »

FASTA2,079212,571
Isoform 3.

Checksum: 765727236C2B47C8
Show »

FASTA2,091213,691
Isoform 4.

Checksum: A5ECD51E41D40F1F
Show »

FASTA2,080212,643
Isoform 5.

Checksum: 4C67CE62D57E590F
Show »

FASTA2,093215,401

References

« Hide 'large scale' references
[1]"The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA."
Von Lindern M., Fornerod M., Van Baal S., Jaegle M., De Wit T., Buijs A., Grosveld G.
Mol. Cell. Biol. 12:1687-1697(1992) [PubMed: 1549122] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT SER-574.
Tissue: Testis.
[2]"Homo sapiens mRNA for KIAA0023 splice variant 1 protein."
Nagase T., Kikuno R., Ohara O.
Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
Tissue: Brain.
[3]"Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1."
Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y., Sato S., Nagase T., Seki N., Ishikawa K., Tabata S.
DNA Res. 1:27-35(1994) [PubMed: 7584026] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
[4]"DNA sequence and analysis of human chromosome 9."
Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., Bagguley C.L. expand/collapse author list , Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A., Frankland J.A., French L., Fricker D.G., Garner P., Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S., Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E., Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D., Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E., Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K., Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M., Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J., Dunham I.
Nature 429:369-374(2004) [PubMed: 15164053] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[5]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4), VARIANT SER-574.
Tissue: Placenta and Testis.
[6]"The human CAN protein, a putative oncogene product associated with myeloid leukemogenesis, is a nuclear pore complex protein that faces the cytoplasm."
Kraemer D., Wozniak R.W., Blobel G., Radu A.
Proc. Natl. Acad. Sci. U.S.A. 91:1519-1523(1994) [PubMed: 8108440] [Abstract]
Cited for: CHARACTERIZATION.
[7]"The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and the novel nuclear pore component Nup88."
Fornerod M., van Deursen J.M., van Baal S., Reynolds A., Davis D., Murti K.G., Fransen J., Grosveld G.
EMBO J. 16:807-816(1997) [PubMed: 9049309] [Abstract]
Cited for: INTERACTION WITH XPO1.
[8]"Exportin-5, a novel karyopherin, mediates nuclear export of double-stranded RNA binding proteins."
Brownawell A.M., Macara I.G.
J. Cell Biol. 156:53-64(2002) [PubMed: 11777942] [Abstract]
Cited for: INTERACTION WITH XPO5.
[9]"Large-scale characterization of HeLa cell nuclear phosphoproteins."
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-430 AND THR-437, MASS SPECTROMETRY.
Tissue: Epithelium.
[10]"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.
Cell 127:635-648(2006) [PubMed: 17081983] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-940 AND SER-1081, MASS SPECTROMETRY.
Tissue: Epithelium.
[11]"Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.
J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1081, MASS SPECTROMETRY.
Tissue: Epithelium.
[12]"Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry."
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40, MASS SPECTROMETRY.
[13]"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis."
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III
J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-666, MASS SPECTROMETRY.
[14]"Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M.
Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-416; SER-646; SER-651; SER-657; SER-666; THR-670; SER-678; SER-940; SER-970; SER-1081; THR-1156; SER-1181; THR-1203; THR-1312; SER-1333 AND SER-1356, MASS SPECTROMETRY.
[15]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-430; SER-433; THR-434; THR-437; THR-439; SER-666; THR-670; SER-678; SER-940; SER-970; SER-974; SER-985; THR-987; SER-989 AND SER-1963, MASS SPECTROMETRY.
[16]Colinge J., Superti-Furga G., Bennett K.L.
Submitted (OCT-2008) to UniProtKB
Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY.
[17]"The consensus coding sequences of human breast and colorectal cancers."
Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. expand/collapse author list , Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., Velculescu V.E.
Science 314:268-274(2006) [PubMed: 16959974] [Abstract]
Cited for: VARIANTS [LARGE SCALE ANALYSIS] ALA-424; LEU-1378 AND VAL-1392.
+Additional computationally mapped references.

Cross-references

Sequence databases

X64228 mRNA. Translation: CAA45535.1.
AB159230 mRNA. Translation: BAD07398.1. Different initiation.
D14689 mRNA. Translation: BAA03515.1.
AL157938 Genomic DNA. Translation: CAI41111.1.
BC045620 mRNA. Translation: AAH45620.2.
BC105998 mRNA. Translation: AAI05999.1.
IPIIPI00183294.
IPI00646361.
IPI00900318.
IPI00900325.
IPI00900331.
PIRS26058.
RefSeqNP_005076.3.
UniGeneHs.654530

3D structure databases

EntryMethodResolution (Å)ChainPositionsPDBsum
2OITX-ray1.65A1-434[»]
3FHCX-ray2.80A1-405[»]
SMRP35658. Positions 1-434.
ModBaseSearch...

Protein-protein interaction databases

IntActP35658. 2 interactions.

PTM databases

PhosphoSiteP35658.

Proteomic databases

PRIDEP35658.

Genome annotation databases

EnsemblENSG00000126883. Homo sapiens. [Contig view]
GeneID8021.
KEGGhsa:8021.

Organism-specific databases

GeneCardsGC09P132990.
H-InvDBHIX0022356.
HGNCHGNC:8064. NUP214.
HPAHPA018404.
MIM114350. gene.
Orphanet52688. Myelodysplastic syndromes.
86839. Refractory anemia with excess blasts.
PharmGKBPA31851.
HUGESearch...
GenAtlasSearch...

Phylogenomic databases

HOVERGENP35658.
OMAP35658. HLEQKKK.

Enzyme and pathway databases

Pathway_Interaction_DBbmppathway. BMP receptor signaling.
smad2_3pathway. Regulation of cytoplasmic and nuclear SMAD2/3 signaling.
nfat_3pathway. Role of Calcineurin-dependent NFAT signaling in lymphocytes.
ReactomeREACT_6185. HIV Infection.

Gene expression databases

ArrayExpressP35658.
BgeeP35658.
CleanExHS_NUP214.
GermOnlineENSG00000126883. Homo sapiens.

Family and domain databases

InterProIPR015943. WD40/YVTN_repeat-like.
IPR001680. WD40_repeat.
[Graphical view]
Gene3DG3DSA:2.130.10.10. WD40/YVTN_repeat-like. 1 hit.
SMARTSM00320. WD40. 2 hits.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio30584.
SOURCESearch...

Entry information

Entry nameNU214_HUMAN
AccessionPrimary (citable) accession number: P35658
Secondary accession number(s): A6NFQ0 expand/collapse secondary AC list , Q15010, Q3KQZ0, Q5JUP7, Q75R47, Q86XD3
Entry history
Integrated into UniProtKB/Swiss-Prot: June 1, 1994
Last sequence update: July 22, 2008
Last modified: June 16, 2009
This is version 93 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

Human chromosome 9

Human chromosome 9: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents